These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 19604403

  • 1. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury.
    Buss A, Pech K, Kakulas BA, Martin D, Schoenen J, Noth J, Brook GA.
    BMC Neurol; 2009 Jul 15; 9():32. PubMed ID: 19604403
    [Abstract] [Full Text] [Related]

  • 2. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury.
    Jones LL, Margolis RU, Tuszynski MH.
    Exp Neurol; 2003 Aug 15; 182(2):399-411. PubMed ID: 12895450
    [Abstract] [Full Text] [Related]

  • 3. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue.
    Tang X, Davies JE, Davies SJ.
    J Neurosci Res; 2003 Feb 01; 71(3):427-44. PubMed ID: 12526031
    [Abstract] [Full Text] [Related]

  • 4. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors.
    Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH.
    J Neurosci; 2002 Apr 01; 22(7):2792-803. PubMed ID: 11923444
    [Abstract] [Full Text] [Related]

  • 5. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries.
    Davies JE, Tang X, Denning JW, Archibald SJ, Davies SJ.
    Eur J Neurosci; 2004 Mar 01; 19(5):1226-42. PubMed ID: 15016081
    [Abstract] [Full Text] [Related]

  • 6. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition.
    Jones LL, Sajed D, Tuszynski MH.
    J Neurosci; 2003 Oct 15; 23(28):9276-88. PubMed ID: 14561854
    [Abstract] [Full Text] [Related]

  • 7. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.
    McKeon RJ, Jurynec MJ, Buck CR.
    J Neurosci; 1999 Dec 15; 19(24):10778-88. PubMed ID: 10594061
    [Abstract] [Full Text] [Related]

  • 8. Chondroitin sulfate proteoglycans in the developing central nervous system. II. Immunocytochemical localization of neurocan and phosphacan.
    Meyer-Puttlitz B, Junker E, Margolis RU, Margolis RK.
    J Comp Neurol; 1996 Feb 26; 366(1):44-54. PubMed ID: 8866845
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury.
    Andrews EM, Richards RJ, Yin FQ, Viapiano MS, Jakeman LB.
    Exp Neurol; 2012 May 26; 235(1):174-87. PubMed ID: 21952042
    [Abstract] [Full Text] [Related]

  • 11. A comprehensive atlas of Aggrecan, Versican, Neurocan and Phosphacan expression across time in wildtype retina and in retinal degeneration.
    Matsuyama A, Kalargyrou AA, Smith AJ, Ali RR, Pearson RA.
    Sci Rep; 2022 May 04; 12(1):7282. PubMed ID: 35508614
    [Abstract] [Full Text] [Related]

  • 12. Lesion-induced differential expression and cell association of Neurocan, Brevican, Versican V1 and V2 in the mouse dorsal root entry zone.
    Beggah AT, Dours-Zimmermann MT, Barras FM, Brosius A, Zimmermann DR, Zurn AD.
    Neuroscience; 2005 May 04; 133(3):749-62. PubMed ID: 15896911
    [Abstract] [Full Text] [Related]

  • 13. Growth-modulating molecules are associated with invading Schwann cells and not astrocytes in human traumatic spinal cord injury.
    Buss A, Pech K, Kakulas BA, Martin D, Schoenen J, Noth J, Brook GA.
    Brain; 2007 Apr 04; 130(Pt 4):940-53. PubMed ID: 17314203
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Spatiotemporal distribution of chondroitin sulfate proteoglycans after optic nerve injury in rodents.
    Pearson CS, Solano AG, Tilve SM, Mencio CP, Martin KR, Geller HM.
    Exp Eye Res; 2020 Jan 04; 190():107859. PubMed ID: 31705897
    [Abstract] [Full Text] [Related]

  • 16. Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes.
    Smith GM, Strunz C.
    Glia; 2005 Nov 15; 52(3):209-18. PubMed ID: 15968632
    [Abstract] [Full Text] [Related]

  • 17. Intraventricular hemorrhage induces deposition of proteoglycans in premature rabbits, but their in vivo degradation with chondroitinase does not restore myelination, ventricle size and neurological recovery.
    Vinukonda G, Zia MT, Bhimavarapu BB, Hu F, Feinberg M, Bokhari A, Ungvari Z, Fried VA, Ballabh P.
    Exp Neurol; 2013 Sep 15; 247():630-44. PubMed ID: 23474192
    [Abstract] [Full Text] [Related]

  • 18. Chondroitin sulphate proteoglycans in the CNS injury response.
    Morgenstern DA, Asher RA, Fawcett JW.
    Prog Brain Res; 2002 Sep 15; 137():313-32. PubMed ID: 12440375
    [Abstract] [Full Text] [Related]

  • 19. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.
    Massey JM, Amps J, Viapiano MS, Matthews RT, Wagoner MR, Whitaker CM, Alilain W, Yonkof AL, Khalyfa A, Cooper NG, Silver J, Onifer SM.
    Exp Neurol; 2008 Feb 15; 209(2):426-45. PubMed ID: 17540369
    [Abstract] [Full Text] [Related]

  • 20. Chondroitin sulfate proteoglycans in spinal cord contusion injury and the effects of chondroitinase treatment.
    Iaci JF, Vecchione AM, Zimber MP, Caggiano AO.
    J Neurotrauma; 2007 Nov 15; 24(11):1743-59. PubMed ID: 18001203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.